Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
Glenfield Hospital · University Hospitals of Leicester NHS Trust · +12 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,200
total citations
- FWCI
- 66.40
- Percentile
- 100%
- References
- 28
Citations per year
Authors
8- IPIan PavordCorresponding
Glenfield Hospital, University Hospitals of Leicester NHS Trust
- SKStephanie Korn
Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz
- PHPeter Howarth
Southampton General Hospital
- EREugene R. Bleecker
Wake Forest University
- RBRoland Buhl
Johannes Gutenberg University Mainz, University Medical Center of the Johannes Gutenberg University Mainz
Topics & keywords
Topics
Keywords
- Mepolizumab
- Medicine
- Placebo
- Asthma
- Internal medicine
- Emergency department
- Randomized controlled trial
- Interleukin 5
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.